These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23552735)

  • 1. Genome-wide profiling reveals transcriptional repression of MYC as a core component of NR4A tumor suppression in acute myeloid leukemia.
    Boudreaux SP; Ramirez-Herrick AM; Duren RP; Conneely OM
    Oncogenesis; 2012 Jul; 1(7):e19. PubMed ID: 23552735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome Wide Mapping of NR4A Binding Reveals Cooperativity with ETS Factors to Promote Epigenetic Activation of Distal Enhancers in Acute Myeloid Leukemia Cells.
    Duren RP; Boudreaux SP; Conneely OM
    PLoS One; 2016; 11(3):e0150450. PubMed ID: 26938745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Oncogenic Super Enhancers in MYC-Dependent AML Using a Small Molecule Activator of NR4A Nuclear Receptors.
    Call SG; Duren RP; Panigrahi AK; Nguyen L; Freire PR; Grimm SL; Coarfa C; Conneely OM
    Sci Rep; 2020 Feb; 10(1):2851. PubMed ID: 32071334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nuclear orphan receptor NR4A1 and NR4A3 as tumor suppressors in hematologic neoplasms.
    Wenzl K; Troppan K; Neumeister P; Deutsch AJ
    Curr Drug Targets; 2015; 16(1):38-46. PubMed ID: 25410408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced NR4A gene dosage leads to mixed myelodysplastic/myeloproliferative neoplasms in mice.
    Ramirez-Herrick AM; Mullican SE; Sheehan AM; Conneely OM
    Blood; 2011 Mar; 117(9):2681-90. PubMed ID: 21205929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug targeting of NR4A nuclear receptors for treatment of acute myeloid leukemia.
    Boudreaux SP; Duren RP; Call SG; Nguyen L; Freire PR; Narayanan P; Redell MS; Conneely OM
    Leukemia; 2019 Jan; 33(1):52-63. PubMed ID: 29884904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NR4A1 and NR4A3 restrict HSC proliferation via reciprocal regulation of C/EBPα and inflammatory signaling.
    Freire PR; Conneely OM
    Blood; 2018 Mar; 131(10):1081-1093. PubMed ID: 29343483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nuclear orphan receptors NR4A as therapeutic target in cancer therapy.
    Deutsch AJ; Angerer H; Fuchs TE; Neumeister P
    Anticancer Agents Med Chem; 2012 Nov; 12(9):1001-14. PubMed ID: 22583411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-heterogeneity in transcription and chemoresistant property of leukemia-initiating cells in murine Setd2
    Song J; Du L; Liu P; Wang F; Zhang B; Xie Y; Lu J; Jin Y; Zhou Y; Lv G; Zhang J; Chen S; Chen Z; Sun X; Zhang Y; Huang Q
    Cancer Commun (Lond); 2021 Sep; 41(9):867-888. PubMed ID: 34196511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia.
    Mullican SE; Zhang S; Konopleva M; Ruvolo V; Andreeff M; Milbrandt J; Conneely OM
    Nat Med; 2007 Jun; 13(6):730-5. PubMed ID: 17515897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of T-lymphocytic leukemia-initiating stem cells residing in a small subset of patients with acute myeloid leukemic disease.
    Risueño RM; Campbell CJ; Dingwall S; Levadoux-Martin M; Leber B; Xenocostas A; Bhatia M
    Blood; 2011 Jun; 117(26):7112-20. PubMed ID: 21562049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diminished AHR Signaling Drives Human Acute Myeloid Leukemia Stem Cell Maintenance.
    Ly M; Rentas S; Vujovic A; Wong N; Moreira S; Xu J; Holzapfel N; Bhatia S; Tran D; Minden MD; Draper JS; Hope KJ
    Cancer Res; 2019 Nov; 79(22):5799-5811. PubMed ID: 31519687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of c-myc gene accompanied by PU.1 deficiency in radiation-induced acute myeloid leukemia in mice.
    Hirouchi T; Takabatake T; Yoshida K; Nitta Y; Nakamura M; Tanaka S; Ichinohe K; Oghiso Y; Tanaka K
    Exp Hematol; 2008 Jul; 36(7):871-85. PubMed ID: 18375040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of mRNA Expressions of TOX and NR4As in CD8+ T cells in Acute Leukemia.
    Mohammadi M; Asgarian-Omran H; Najafi B; Najafi A; Valadan R; Karami H; Naderisoraki M; Alizadeforoutan M; Shekarriz R; Tehrani M
    Iran J Immunol; 2023 Dec; 20(4):438-445. PubMed ID: 37961948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NR4A Receptors Differentially Regulate NF-κB Signaling in Myeloid Cells.
    McEvoy C; de Gaetano M; Giffney HE; Bahar B; Cummins EP; Brennan EP; Barry M; Belton O; Godson CG; Murphy EP; Crean D
    Front Immunol; 2017; 8():7. PubMed ID: 28167941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preleukemia and Leukemia-Initiating Cell Activity in inv(16) Acute Myeloid Leukemia.
    Pulikkan JA; Castilla LH
    Front Oncol; 2018; 8():129. PubMed ID: 29755956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NR4A subfamily of nuclear receptors: potential new therapeutic targets for the treatment of inflammatory diseases.
    Rodríguez-Calvo R; Tajes M; Vázquez-Carrera M
    Expert Opin Ther Targets; 2017 Mar; 21(3):291-304. PubMed ID: 28055275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of NR4A family members in myeloid cells and leukemia.
    Boulet S; Le Corre L; Odagiu L; Labrecque N
    Curr Res Immunol; 2022; 3():23-36. PubMed ID: 35496823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reprogramming of RNA m6A Modification Is Required for Acute Myeloid Leukemia Development.
    Liu W; Wang Y; Yao S; Han G; Hu J; Yin R; Zhou F; Cheng Y; Zhang H
    Genomics Proteomics Bioinformatics; 2024 Jun; ():. PubMed ID: 38913865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
    Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
    Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.